Medtronic (2M6) Stock Statistics & Valuation Metrics

Medtronic has a market cap or net worth of $94.71B. The enterprise value is €137.03B.

Medtronic has 1,281,264,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medtronic’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.08%.

The current PE Ratio of Medtronic is 23.21. Medtronic’s PEG ratio is 2.37.

In the last 12 months, Medtronic had revenue of 33.54B and earned 4.66B in profits. Earnings per share was 3.63.

In the last 12 months, operating cash flow was 7.04B and capital expenditures -1.86B, giving a free cash flow of 5.18B billion.

Medtronic pays an annual dividend of €0.618, resulting in a dividend yield of 3.36%

Medtronic upcoming earnings date is Aug 19, 2025, Before Open (Confirmed).

Medtronic as a current ratio of 1.85, with Debt / Equity ratio of 59.38%

In the past 12 months, Medtronic has paid 936.00M in taxes.

Medtronic EV to EBITDA ratio is 22.59, with an EV/FCF ratio of 25.94.

Medtronic has $2.22B in cash and marketable securities with $28.52B in debt, giving a net cash position of $26.30B billion.

Gross margin is 46.76%, with operating margin of 17.76%, and net profit margin of 13.90%.

The average price target for Medtronic is $82.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy